These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17367304)

  • 1. Systematic literature review: quality of life associated with insulin pump use in Type 1 diabetes.
    Barnard KD; Lloyd CE; Skinner TC
    Diabet Med; 2007 Jun; 24(6):607-17. PubMed ID: 17367304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation.
    Cummins E; Royle P; Snaith A; Greene A; Robertson L; McIntyre L; Waugh N
    Health Technol Assess; 2010 Feb; 14(11):iii-iv, xi-xvi, 1-181. PubMed ID: 20223123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrative review of the psychosocial facilitators and challenges of continuous subcutaneous insulin infusion therapy in type 1 diabetes.
    Payk M; Robinson T; Davis D; Atchan M
    J Adv Nurs; 2018 Mar; 74(3):528-538. PubMed ID: 28960449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps.
    Potti LG; Haines ST
    J Am Pharm Assoc (2003); 2009; 49(1):e1-13; quiz e14-7. PubMed ID: 19196588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
    Roze S; Smith-Palmer J; Valentine WJ; Cook M; Jethwa M; de Portu S; Pickup JC
    J Med Econ; 2016; 19(3):236-42. PubMed ID: 26510389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous subcutaneous insulin infusion benefits quality of life in preschool-age children with type 1 diabetes mellitus.
    Opipari-Arrigan L; Fredericks EM; Burkhart N; Dale L; Hodge M; Foster C
    Pediatr Diabetes; 2007 Dec; 8(6):377-83. PubMed ID: 18036064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric quality of life in transitioning to the insulin pump: does prior regimen make a difference?
    Cogen FR; Henderson C; Hansen JA; Streisand R
    Clin Pediatr (Phila); 2007 Nov; 46(9):777-9. PubMed ID: 17585009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of educational components and strategies associated with insulin pump therapy: a systematic review.
    Jayasekara RS; Munn Z; Lockwood C
    Int J Evid Based Healthc; 2011 Dec; 9(4):346-61. PubMed ID: 22093386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Position statement: Continuous subcutaneous insulin infusion in very young children with type 1 diabetes.
    Eugster EA; Francis G;
    Pediatrics; 2006 Oct; 118(4):e1244-9. PubMed ID: 17015512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits of continuous subcutaneous insulin infusion on quality of life.
    Lukács A; Kiss-Tóth E; Varga B; Soós A; Takác P; Barkai L
    Int J Technol Assess Health Care; 2013 Jan; 29(1):48-52. PubMed ID: 23270655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-economic analysis of real-time continuous glucose monitoring in people with Type 1 diabetes.
    Roze S; Saunders R; Brandt AS; de Portu S; Papo NL; Jendle J
    Diabet Med; 2015 May; 32(5):618-26. PubMed ID: 25483869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do We Need Updated Guidelines on the Use of Insulin Pump Therapy in Type 2 Diabetes? A Review of National and International Practice Guidelines.
    Cohen O; Valentine W
    J Diabetes Sci Technol; 2016 Nov; 10(6):1388-1398. PubMed ID: 27621141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of quality of life and family burden issues during insulin pump therapy in children with Type 1 diabetes mellitus--a large-scale multicentre pilot study.
    Müller-Godeffroy E; Treichel S; Wagner VM;
    Diabet Med; 2009 May; 26(5):493-501. PubMed ID: 19646189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Indications for the use of continuous subcutaneous insulin infusion in pediatric patients with type 1 diabetes mellitus].
    Espejel-Huerta D; Antillón-Ferreira CA; Iglesias-Leboreiro J; Bernárdez-Zapata I; Martínez-Ramos Méndez A; Rendón-Macías ME
    Rev Med Inst Mex Seguro Soc; 2016; 54(1):64-9. PubMed ID: 26820201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin: economic comparison in adult and adolescent type 1 diabetes mellitus in Australia.
    Cohen N; Minshall ME; Sharon-Nash L; Zakrzewska K; Valentine WJ; Palmer AJ
    Pharmacoeconomics; 2007; 25(10):881-97. PubMed ID: 17887808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlates of quality of life in adults with type 1 diabetes treated with continuous subcutaneous insulin injection.
    Franciosi M; Maione A; Pomili B; Amoretti R; Busetto E; Capani F; Bruttomesso D; Di Bartolo P; Girelli A; Leonetti F; Morviducci L; Ponzi P; Vitacolonna E; Nicolucci A
    Nutr Metab Cardiovasc Dis; 2010 Jan; 20(1):7-14. PubMed ID: 19747804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of the treatment with continuous subcutaneous insulin infusion (CSII) in the improvement of the quality of life of patients with type 1 diabetes mellitus].
    Casas-Oñate ML; Montoya-Martínez D
    Enferm Clin; 2010; 20(4):216-21. PubMed ID: 20561806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin pump treatment in children and adolescents with type 1 diabetes: experiences of the German working group for insulin pump treatment in pediatric patients.
    Kapellen TM; Klinkert C; Heidtmann B; Jakisch B; Haberland H; Hofer SE; Holl RW
    Postgrad Med; 2010 May; 122(3):98-105. PubMed ID: 20463419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of dermatological side effects of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes.
    Binder E; Lange O; Edlinger M; Meraner D; Abt D; Moser C; Steichen E; Hofer SE
    Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):260-4. PubMed ID: 25607337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAR 3 randomized controlled trial to compare sensor-augmented insulin pump therapy with multiple daily injections in the treatment of type 1 diabetes: research design, methods, and baseline characteristics of enrolled subjects.
    Davis SN; Horton ES; Battelino T; Rubin RR; Schulman KA; Tamborlane WV
    Diabetes Technol Ther; 2010 Apr; 12(4):249-55. PubMed ID: 20210562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.